ARL13B通过激活VEGFA-VEGFR2信号促进血管生成和胶质瘤生长
本研究利用基因工程小鼠模型、颅内移植胶质瘤模型和皮下黑色素瘤模型,发现内皮细胞ARL13B调控视网膜和脑的血管发育,并通过与VEGFR2相互作用调控其膜和纤毛定位及下游信号,从而促进肿瘤血管生成和肿瘤生长;ARL13B在人类胶质瘤中高表达且与预后不良相关,并受ZEB1转录调控,通过激活Hedgehog信号增强VEGFA表达。
要点
- 内皮细胞ARL13B调控小鼠视网膜和脑的血管发育,并促进颅内胶质瘤和皮下黑色素瘤生长的血管生成。
- ARL13B与VEGFR2相互作用,调控其膜和纤毛定位并激活下游信号。
- ARL13B在人类胶质瘤中高表达,与预后不良相关,受ZEB1转录调控并通过Hedgehog信号增强VEGFA表达。
核心结论
- ARL13B通过激活VEGFA-VEGFR2信号促进血管生成和肿瘤生长。
- 靶向ARL13B可能成为开发抗胶质瘤或抗黑色素瘤治疗的潜在途径。
研究设计与样本
- 采用基因工程小鼠模型研究内皮细胞ARL13B过表达和缺失对视网膜和脑血管的影响。
- 采用颅内移植胶质瘤模型和皮下植入黑色素瘤模型检测ARL13B对肿瘤生长和血管生成的作用。
主要发现
- 内皮细胞ARL13B调控小鼠视网膜和脑的血管发育。
- 内皮细胞ARL13B通过控制肿瘤血管生成调控颅内移植胶质瘤细胞和皮下植入黑色素瘤细胞的生长。
- ARL13B与VEGFR2相互作用,调控VEGFR2的膜和纤毛定位并激活内皮细胞下游信号。
- ARL13B在人类胶质瘤中高表达,与胶质瘤患者预后不良相关。
- ARL13B受ZEB1转录调控,通过激活胶质瘤细胞中Hedgehog信号增强VEGFA表达。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tumor angiogenesis is essential for solid tumor progression, invasion and metastasis. The aim of this study was to identify potential signaling pathways involved in tumor angiogenesis. METHODS: Genetically engineered mouse models were used to investigate the effects of endothelial ARL13B(ADP-ribosylation factor-like GTPase 13B) over-expression and deficiency on retinal and cerebral vasculature. An intracranially transplanted glioma model and a subcutaneously implanted melanoma model were employed to examine the effects of ARL13B on tumor growth and angiogenesis. Immunohistochemistry was used to measure ARL13B in glioma tissues, and scRNA-seq was used to analyze glioma and endothelial ARL13B expression. GST-fusion protein-protein interaction and co-immunoprecipitation assays were used to determine the ARL13B-VEGFR2 interaction. Immunobloting, qPCR, dual-luciferase reporter assay and functional experiments were performed to evaluate the effects of ARL13B on VEGFR2 activation. RESULTS: Endothelial ARL13B regulated vascular development of both the retina and brain in mice. Also, ARL13B in endothelial cells regulated the growth of intracranially transplanted glioma cells and subcutaneously implanted melanoma cells by controlling tumor angiogenesis. Interestingly, this effect was attributed to ARL13B interaction with VEGFR2, through which ARL13B regulated the membrane and ciliary localization of VEGFR2 and consequently activated its downstream signaling in endothelial cells. Consistent with its oncogenic role, ARL13B was highly expressed in human gliomas, which was well correlated with the poor prognosis of glioma patients. Remarkably, ARL13B, transcriptionally regulated by ZEB1, enhanced the expression of VEGFA by activating Hedgehog signaling in glioma cells. CONCLUSIONS: ARL13B promotes angiogenesis and tumor growth by activating VEGFA-VEGFR2 signaling. Thus, targeting ARL13B might serve as a potential approach for developing an anti-glioma or anti-melanoma therapy.
引用
- Chen L, Xie X, Wang T, et al. ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling. Neuro Oncol. 2023. PMID: 36322624. doi:10.1093/neuonc/noac245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。